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Abstract Botulinum neurotoxins type D and F are zinc-
endopeptidases with a unique specificity for VAMP/synaptobre-
vin, an essential component of the exocytosis apparatus. VAMP 
contains two copies of a nine residue motif, termed VI and V2, 
which are determinants of the interaction with tetanus and 
botulinum B and G neurotoxins. Here, we show that VI plays a 
major role in VAMP recognition by botulinum neurotoxins D 
and F and that V2 is also involved in F binding. Site-directed 
mutagenesis of VI and V2 indicates that different residues are 
the determinants of the VAMP interaction with the two 
endopeptidases. The study of the VAMP-neurotoxins interaction 
suggest a pairing of the VI and V2 segments. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Clostridial neurotoxms form a novel group of zinc-endo-
peptidases that act in the cytosol of neurons and block neuro-
transmitter release [1]. They consist of two disulfide-linked 
chains: the larger one (H chain, 100 kDa) binds specifically 
to synaptic terminals and promotes the entry of the shorter 
chain (L chain, 50 kDa) to the cytosol. The metalloproteolytic 
activity of these neurotoxins is associated to the L chain [2-5]. 
The only known proteolytic substrate of tetanus neurotoxin 
(TeNT) and of botulinum neurotoxins serotype B, D , F and 
G (BoNT/B, BoNT/D, BoNT/F, BoNT/G) is VAMP/synapto-
brevin (VAMP) (Fig. 1), which is cleaved at single different 
peptide bonds [6-14]. V A M P is a tail-anchored membrane 
protein of exocytotic vesicles and the cellular consequences 
of its cleavage demonstrate that it is an essential component 
of the exocytotic machinery [4,15,16]. V A M P is a family of 
different isoforms [17-22] and neurotoxin-sensitive isoforms 
are present in many non-neuronal tissues [23,24]. Conse-
quently, the lack of activity of clostridial neurotoxins on 
non-neuronal cells is due to the fact that they do not bind 
to these cells because of their lack of cell surface neurotoxin 
receptors, rather than to the fact that they do not possess the 
neurotoxin intracellular substrates. 
TeNT, BoNT/B, BoNT/D, BoNT/F and BoNT/G cleave 
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V A M P within a conserved region and it has been suggested 
that their substrate specificity is due to the recognition of the 
segment encompassing the cleavage site and of a nine residue 
motif, termed S N A R E motif from the collective name of 
SNAREs given to the three clostridial neurotoxin substrates 
[16,17,25]. The motif is present in two copies (VI and V2) in 
the V A M P molecule (see Fig. 1). Recently, we have obtained 
experimental evidence for the involvement of VI in VAMP-
TeNT interaction, whereas V2 is a determinant of the V A M P 
proteolysis by BoNT/B and BoNT/G [26,27]. Here, we extend 
these studies to BoNT/D and BoNT/F and show that their 
interaction with V A M P differs in terms of ionic strength sen-
sitivity and of S N A R E motif residues involved. These results 
not only uncover the molecular basis of the recognition and 
cleavage of V A M P by the clostridial neurotoxins, but also 
provide novel information on the possible spatial arrange-
ments of the S N A R E motifs of V A M P . 
2. Materials and methods 
2.1. Proteins, peptides and chemicals 
BoNT/D and BoNT/F were prepared as detailed before [28,29] and 
immobilized-metal-ion affinity chromatography was used to remove 
traces of contaminant proteases [30]. 
2.2. Bacterial strains, plasmid construction and VAMP mutagenesis 
The PCR product of rat VAMP-2 gene was cloned into a pEMBL 
vector as detailed before [26] and used to produce mutated or deleted 
proteins. The D41N,E41Q mutant of rat VAMP-2 was obtained as 
previously described [26]. Uracil containing ssDNA was produced 
within BW313, an E. coli dut- ung- strain, for generation of 
VAMP-2 mutants by site-directed mutagenesis. The in vitro reactions 
were performed as described by Kunkel et al. [31]. The following 
oligonucleotides were used to generate the corresponding mutants: 
5'-ATTCACCCTCGCGATGTCCACCA-3' for VAMP-2M46A, 5'-
ATGATGTCCGCCACCTCATC-3' for VAMP-2V43A, 5'-AGGG-
CATCTACGCGATCATCC-3' for VAMP-2A67V, 5'-CCTCAT-
GATGTTAACCACCTCATC-3' for VAMP-2 D44N, and 5'-
CTTGTCCACCCTCACCTGGGCCTGGGTCTGCT-3' to make 
the deletion D40-46 by looping out. The sequence of the mutated 
genes was checked by dideoxy sequencing using fmole DNA sequenc-
ing system (Promega). Wild-type VAMP-2 and mutants were sub-
cloned into BamHl and EcoRl sites of pGEX-KG vector [32] and 
transformed into the AB 1899 strain of E. coli. 
Rat VAMP-2 and its mutants were expressed as GST-fusion pro-
teins and purified by affinity chromatography on GSH-agarose matrix 
(Pharmacia). 
2.3. Assay of proteolytic activity 
After preincubation with 10 mM DTT in 150 mM NaCl, 10 mM 
Na2HP04 , pH 7.4, for 30 min at 37°C, BoNT/F (100 nM) or BoNT/D 
(25 nM) was added to the reaction mixture containing one of the 
different GST-fusion proteins (50 ug/ml). Proteolysis was carried out 
for 2 h in 150 mM NaCl, 10 mM Na2HP04 , pH 7.4, at 37°C [12]. 
Under these conditions of toxin concentration and incubation time, 
the extent of proteolysis is nearly complete with wild-type GST-
VAMP, thus allowing a valuable comparison of data obtained with 
the different VAMP mutants. To test the ionic strength sensitivity of 
00f4-5793/97/Sf7.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / / S 0 0 1 4 - 5 7 9 3 ( 9 7 ) 0 0 4 8 2 - l 
340 R Pellizzari et al.lFEBS Letters 409 (1997) 339-342 
the proteolytic activity of BoNT/D and BoNT/F, buffers containing 
10 mM Na2HPC>4, pH 7.4, and NaCl in the range of concentration of 
0.1, 0.2, 0.5 or 1 M were used. The time course of GST-VAMP 
proteolysis was estimated by separation of the VAMP fragments by 
SDS-PAGE and quantitation of the Coomassie Blue stained bands 
with a dual wavelength Shimadzu CS-630 densitometer, as described 
before [12]. 
3. Results and discussion 
BoNT/F and BoNT/D cleave adjacent peptide bonds of 
VAMP: they hydrolyse the Gln58/Lys59 and Lys59/Leu60 pep-
tide bonds (rat VAMP-2 numbering), respectively [7,9,14]. 
Together with the fact that their L chains have closely similar 
sequences [33], this suggested the possibility that their inter-
action with VAMP is based on similar residues and forces. 
However, a preliminary analysis of the effects of ionic strength 
on VAMP proteolysis indicates that this is not the case. Fig. 2 
shows that 0.5 M NaCl abolishes the proteolytic activity of 
BoNT/F, whereas it has no effect on BoNT/D activity. Such 
inhibition of BoNT/F proteolytic activity is not due to its 
denaturation induced by high molarity solutions of NaCl be-
cause VAMP is fully proteolysed by a sample of BoNT/F, 
which was treated with 0.5 M NaCl and then diluted to a 
final NaCl concentration of 0.1 M (not shown). The BoNT/ 
B cleavage of VAMP was previously found to be influenced 
by ionic strength and this effect was dependent on the nega-
tively charged residues of the V2 motif [13,27]. 
To identify VAMP residues which are determinants of the 
interaction with BoNT/D and BoNT/F and which could ac-
count for such a diverse effect of ionic strength, a site-directed 
mutagenesis approach was undertaken. Previous results had 
shown that the specific recognition of VAMP by clostridial 
neurotoxins is mediate by : (i) binding of the VAMP residues 
at and around the cleavage site [13,34] and (ii) two segments 
of VAMP, which are located amino terminal with respect to 
the cleavage site [25-27]; these two segments are the VI and 
V2 copies of the SNARE motif present in the VAMP mole-
cule (see Fig. 1). The SNARE motif is characterized by an 
alternation of aliphatic residues and of three negatively 
charged amino acids. The peptide bonds of VAMP hydrolysed 
by BoNT/F and BoNT/D are comprised between VI and V2. 
The importance of VI in BoNT/D and BoNT/F proteolysis of 
VAMP was indicated in preliminary experiments with a VI 
deleted VAMP-2 mutant, which was not cleaved at all by 
these two proteases (left panels of Figs. 3 and 4). Hence, 
mutants of the six carboxylate residues, present in the two 
rat VAMP-2 SNARE motifs, were designed together with a 
mutant of Met46, a residue previously shown to affect BoNT/ 
D activity [14]. These VAMP-2 mutants were expressed as 
fusion proteins with GST in E. coli and purified from bacterial 
extract by affinity chromatography on GSH-Sepharose. GST-
VAMP is a good substrate for the neurotoxins [12,26,35]. 
VI plays a major role in the TeNT recognition of VAMP, 
whereas V2 is involved in BoNT/B and BoNT/G binding 
[26,27]. For the remaining two neurotoxins having VAMP-2 
as a target, we found that single substitutions of any of the VI 
Asp or Glu residues with the corresponding Asn or Gin abol-
ish the proteolytic activity of BoNT/F (Fig. 3), whereas such 
substitutions do not affect BoNT/D proteolytic activity (Fig. 
4). The replacement of the carboxylate residues of the V2 
segment with the corresponding amide residues also influences 
the cleavage of VAMP-2 by BoNT/F, but the effect of such 
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Fig. 1. Schematic structure of rat VAMP-2. The N-terminal part is 
proline rich and is not conserved among VAMP isoforms. The cen-
tral grey region is highly conserved and includes the two copies of 
the SNARE motif, indicated by VI and V2. The positions of the 
capital letters correspond to the cleavage sites of tetanus neurotoxin 
(T) and of botulinum neurotoxins type B, D, F and G. The lower 
part of the figure represents the SNARE motif (with -, carboxylate 
residues; h, aliphatic residues; p, polar residues; x, any residue). 
mutations is less pronounced than that of mutating the cor-
responding residues of the VI segment (Fig. 3). All the 
VAMP-2 mutants in the V2 segment are cleaved by BoNT/ 
D at the same rate as the control. Taken together, these re-
sults indicate that carboxylate residues of the VI segment play 
a major role in the interaction of BoNT/F and that also the 
corresponding residues of the V2 segment are implicated. 
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Fig. 2. Effect of ionic strength on the rate of VAMP proteolysis of BoNT/F and BoNT/D. Proteolysis of GST-VAMP2 was carried out in 10 
mM Na2HP04, pH 7.4, with different concentrations of NaCl, as indicated in the picture. The rate of cleavage of GST-VAMP2 protein was 
determined as reported in Section 2. Samples were removed at 5, 30 and 120 min, electrophoresed, and the amount of protein was determined 
by densitometric scanning of Coomassie stained gels. Data are the average of three different experiments, and bars represent SD values. 
BoNT/F with negatively charged residues of VAMP provide 
an explanation for the strong effect of ionic strength on 
BoNT/F proteolysis. Conversely, the lack of effect of such 
mutations on BoNT/D activity is in agreement with its lack 
of sensitivity to ionic strength. 
Recombinant rat VAMP-1 is proteolysed very slowly by 
BoNT/D, and a Val for Met substitution at position 46 is 
held responsible for its resistance to BoNT/D [14]. Fig. 4 
shows that a recombinant rat VAMP-2 presenting the single 
substitution of Met46 with an Ala residue is completely resist-
ant to BoNT/D. These results identify Met46 as the key resi-
due of the VI segment in the interaction of BoNT/D with 
VAMP. 
The present study completes the analysis of the effect of 
mutations of VI and V2 residues on the proteolytic activity 
of the clostridial neurotoxins specific for VAMP. As in the 
case of TeNT, BoNT/B and BoNT/G, the SNARE motifs of 
VAMP are major determinants of the remarkable specificity 
of these metalloproteases. However, in addition to this general 
conclusion, results described here clearly show that different 
residues play different roles in the recognition of VAMP by 
BoNT/F and BoNT/D. The different mode of interaction 
mechanism of these two toxins with their substrate is due to 
structural differences among the two proteases that are diffi-
cult to identify. However, it is difficult to attribute the effects 
described here to particular residues of the BoNT/D and 
BoNT/F molecules. There are several positions which are oc-
cupied by a positively charged residue in BoNT/F sequence 
and by an uncharged residue in the sequence of BoNT/D. In 
particular, around residue 30 of BoNT/F there are three ly-
sines, not conserved in BoNT/D, spaced as the three carbox-
ylates of the SNARE motif, suggesting possible sites for a 
mutagenesis analysis of BoNT/F VAMP recognition. 
The present findings that mutation of negatively charged 
amino acids of both the VI and V2 segments of VAMP in-
fluence the rate of VAMP proteolysis by BoNT/F are in keep-
ing with the suggestion that VI and V2 may be arranged in 
tandem within the VAMP molecule [26]. This particular struc-
tural arrangement may be induced by the interaction with 
clostridial neurotoxins during the cleavage, or be one of the 
conformations adopted by VAMP-2, whose analysis by circu-
lar dichroism and NMR has not revealed elements of secon-
dary structure [10]. The possibility of a pairing of the VI and 
V2 motifs of VAMP-2 is in keeping with a recent study on the 
effect of deletions on the capability of VAMP of supporting 
exocytosis of insulin [34]. The most deleterious deletion was 
found to be that of segment 51-60 which is included in the 
48-62 region between VI and V2 (Fig. 1). The simplest ex-
Fig. 3. Effect of substitution of charged residues of VI and V2 motif of VAMP-2 on the proteolysis by BoNT/F. The percent of cleavage of 
GST-VAMP2 and GST-VAMP2 mutants of the VI and V2 copies of the motif are compared. Numbers in horizontal axis indicate positions of 
VAMP residues that have been mutated and AV1 indicates the mutant deleted of segment 40^f6. Substrates were incubated with BoNT/F 100 
nM, as specified in Section 2. After 2 h at 37°C, samples were electrophoresed, Coomassie blue stained and quantitated by densitometric scan-
ning. Data are averages of four independent experiments and error bars indicate SD values. 
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Fig. 4. Effect of substitution of the charged residues of VI and V2 motif of VAMP-2 and of Met46 on the proteolysis by BoNT/D. Symbols 
and conditions are as in the legend of Fig. 3, except for the concentration of BoNT/D (25 nM). Data are averages of four independent experi-
ments and error bars indicate S.D. values. 
planation of this result is that any shortening of the segment 
connecting VI to V2 prevents their parallel pairing. Deletions 
of VI and V2 also gave non-functional V A M P mutants [34]. 
It was previously shown that deletion of VI leads to a defi-
cient targeting of VAMP-2 to the synaptic vesicles [35,36]. 
These studies indicate that the S N A R E motifs play essential 
roles in V A M P localization and function, and hence they have 
been conserved during evolution, even in the presence of the 
selective pressure exerted on vertebrate animals by the wide-
spread toxigenic Clostridia. 
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